Montara Therapeutics Raises $8M for Brain Disease Treatment Development

Montara Therapeutics secures $8M Seed Financing

Montara Therapeutics (Linkedin), a San Francisco-based therapeutics company, recently closed an $8M seed financing round to advance their innovative brain-targeting drugs for neurological diseases like Alzheimer's and Parkinson's. They are seeking partnerships with biotech firms, manufacturers, and marketing agencies to accelerate their research, production, and outreach efforts.

Funding Amount: $8 million

Industry: Business Consulting and Services

Employee Count: 2-10

CEO: Joel Trammell (CEO Linkedin)

What Montara Therapeutics needs to buy: Biotech firms specializing in neurological drug development, manufacturers with expertise in brain-targeting drugs, and marketing agencies experienced in healthcare outreach are ideal partners for Montara Therapeutics. These collaborations will support their mission to revolutionize treatment options for patients with neurodegenerative diseases and advance their BrainOnly platform.